315 related articles for article (PubMed ID: 9172968)
1. [Maprotiline versus fluvoxamine: comparison of their effects on the hypothalamo-hypophyseal-thyroid axis].
De Mendonça Lima CA; Vandel S; Bonin B; Bechtel P; Carron R
Encephale; 1997; 23(1):48-55. PubMed ID: 9172968
[TBL] [Abstract][Full Text] [Related]
2. Effects of pyridostigmine and naloxone on the abnormal TSH response to TRH during starvation in humans.
Coiro V; Volpi R; Capretti L; Caffarri G; Colla R; Chiodera P
J Investig Med; 1999 May; 47(5):227-31. PubMed ID: 10361382
[TBL] [Abstract][Full Text] [Related]
3. [Hypothalamo-hypophyseal-thyroid axis in recruits and soldiers with male hypogonadism].
Tomov T; Ankov V
Vutr Boles; 1980; 19(5):53-61. PubMed ID: 6777988
[TBL] [Abstract][Full Text] [Related]
4. The combined T3/TRH test in depressed patients and healthy controls.
Schüle C; Baghai TC; Tsikolata V; Zwanzger P; Eser D; Schaaf L; Rupprecht R
Psychoneuroendocrinology; 2005 May; 30(4):341-56. PubMed ID: 15694114
[TBL] [Abstract][Full Text] [Related]
5. Thyroid activity in patients with major depression.
Stipcević T; Pivac N; Kozarić-Kovacić D; Mück-Seler D
Coll Antropol; 2008 Sep; 32(3):973-6. PubMed ID: 18982776
[TBL] [Abstract][Full Text] [Related]
6. Central hypothyroidism--various types of TSH responses to TRH stimulation.
Trejbal D; Sulla I; Trejbalová L; Lazúrová I; Schwartz P; Machánová Y
Endocr Regul; 1994 Mar; 28(1):35-40. PubMed ID: 7949012
[TBL] [Abstract][Full Text] [Related]
7. Effect of pyridostigmine on the thyroid-stimulating hormone response to thyrotropin-releasing hormone in abstinent alcoholics.
Coiro V; Vescovi PP
Alcohol Clin Exp Res; 1997 Oct; 21(7):1308-11. PubMed ID: 9347094
[TBL] [Abstract][Full Text] [Related]
8. Response to total sleep deprivation before and during treatment with fluvoxamine or maprotiline in patients with major depression--results of a double-blind study.
Kasper S; Voll G; Vieira A; Kick H
Pharmacopsychiatry; 1990 May; 23(3):135-42. PubMed ID: 2115680
[TBL] [Abstract][Full Text] [Related]
9. Randomized double-blind study of fluvoxamine and maprotiline in treatment of depression.
de Jonghe F; Swinkels J; Tuynman-Qua H
Pharmacopsychiatry; 1991 Jan; 24(1):21-7. PubMed ID: 1901418
[TBL] [Abstract][Full Text] [Related]
10. [Thyroid function in depressed patients].
De Mendonça Lima CA; Vandel S; Bonin B; Bertschy G; Bizouard P
Encephale; 1996; 22(2):85-94. PubMed ID: 8706626
[TBL] [Abstract][Full Text] [Related]
11. Concentration-response relationship for fluvoxamine using remission as an endpoint: a receiver operating characteristics curve analysis in major depression.
Suzuki Y; Fukui N; Sawamura K; Sugai T; Watanabe J; Ono S; Inoue Y; Ozdemir V; Someya T
J Clin Psychopharmacol; 2008 Jun; 28(3):325-8. PubMed ID: 18480690
[TBL] [Abstract][Full Text] [Related]
12. Thyroid function in anxious and depressed patients.
Rao ML; Vartzopoulos D; Fels K
Pharmacopsychiatry; 1989 Mar; 22(2):66-70. PubMed ID: 2497474
[TBL] [Abstract][Full Text] [Related]
13. [Hypophyseal-hypothalamo-thyroid axis in affective disorders].
Hofmann P; Schrötter KH
Acta Med Austriaca; 1999; 26(4):123-5. PubMed ID: 10526629
[TBL] [Abstract][Full Text] [Related]
14. [Different effects of tricyclic (clomipramine and amitriptyline) and tetracyclic (maprotiline) antidepressors on the release of thyroid stimulating hormone, prolactin and growth hormone to thyrostimulating releasing hormone in patients with psychoaffective disorders (author's transl)].
Schlienger JL; Kapfer MT; Singer L; Stephan F
Acta Psychiatr Belg; 1980; 80(5):584-99. PubMed ID: 6786002
[TBL] [Abstract][Full Text] [Related]
15. Suitable dose and duration of fluvoxamine administration to treat depression.
Morishita S; Arita S
Psychiatry Clin Neurosci; 2003 Apr; 57(2):177-81. PubMed ID: 12667164
[TBL] [Abstract][Full Text] [Related]
16. Effect of endotoxin on hormonal responses to thyrotropin and thyrotropin-releasing hormone in dogs.
Yu AA; Kemppainen RJ; MacDonald JM
Am J Vet Res; 1998 Feb; 59(2):186-91. PubMed ID: 9492934
[TBL] [Abstract][Full Text] [Related]
17. Pituitary-thyroid function in patients with septic shock and its relation with outcome.
Leon-Sanz M; Lorente JA; Larrodera L; Ros P; Alvarez J; Esteban AE; Landin L
Eur J Med Res; 1997 Nov; 2(11):477-82. PubMed ID: 9385118
[TBL] [Abstract][Full Text] [Related]
18. [The effect of a single electroconvulsive shock on pituitary-thyroid-adrenal-gonadal axis function in men with severe depression--preliminary report].
Motta E; Ostrowska Z; Kazibutowska Z; Paluch M; Płonka J; Gołba A
Psychiatr Pol; 2005; 39(3):469-79. PubMed ID: 16149757
[TBL] [Abstract][Full Text] [Related]
19. Aspects of chronic oral treatment with thyrotropin-releasing hormone: the hypothalamic-pituitary-thyroid axis in rats. A study with a pharmacological dose of thyrotropin-releasing hormone.
Duntas L; Roussel JP; Astier H; Keck FS; Rosenthal J; Pfeiffer EF
Pharmacology; 1991; 43(2):106-12. PubMed ID: 1775509
[TBL] [Abstract][Full Text] [Related]
20. [A double-blind controlled study of the efficacy and acceptability of tianeptine in comparison with fluvoxamine in the treatment of depressed alcoholic patients].
Habrat B; Załoga B
Psychiatr Pol; 2006; 40(3):579-97. PubMed ID: 17037821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
